The Phage Futures Congress 2019
JAFRAL is going to attend The Phage Futures 2019 in Washington, [...]
Gene therapy IL-12 clinical trial
JAFRAL is proud to be a GMP manufacturing partner of a consortium/project for first clinical trial on combined electrochemotherapy with gene therapy with Interleukin-12 (IL-12) to improve/enhance local and systemic response to skin tumor treatment.